What is b2a2?
What is b2a2?
bcr-abl (b2a2)-derived peptide vaccine A peptide vaccine consisting of the bcr-abl b2a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity.
What does a positive BCR-ABL mean?
What do the results mean? If your results show you have the BCR-ABL gene, as well as an abnormal amount of white blood cells, you will probably be diagnosed with chronic myeloid leukemia (CML) or Ph-positive, acute lymphoblastic leukemia (ALL).
What is P210 BCR-ABL?
The P210 form of BCR/ABL is found in hematopoietic cells of patients with chronic myeloid leukemia (CML) in stable phase, and in acute lymphoid and myeloid leukemias (6–8), although some patients with acute leukemia and P210 are likely to be cases of CML diagnosed in blast crisis.
What is p210 b3a2 b2a2 major transcript?
There are two major forms of the BCR/ABL fusion gene, involving ABL exon 2, but including different exons of BCR gene. The transcripts b2a2 or b3a2 code for a p210 protein. Another fusion gene leads to the expression of an e1a2 transcript, which codes for a p190 protein.
How do you calculate BCR ABL conversion factor?
To convert BCR-ABL values to IS in this reference laboratory, all values were multiplied by the conversion factor of 1.25. This conversion factor was calculated by dividing the value representing MMR IS (0.10%) by the quantitative value representing a 3-log reduction in this laboratory (0.08%).
What type of protein is ABL?
Tyrosine-protein kinase
Tyrosine-protein kinase ABL1 also known as ABL1 is a protein that, in humans, is encoded by the ABL1 gene (previous symbol ABL) located on chromosome 9.
How do TKIs work?
TKIs are a type of targeted therapy. They work by switching off (inhibiting) the tyrosine kinase made by the BCR-ABL1 gene in leukaemia cells. This slows or stops the bone marrow from making abnormal white blood cells. It also allows the leukaemia cells to mature and die.
What is BCR-ABL ABL ratio?
The log reduction of BCR-ABL:ABL ratio is calculated based on the testing laboratory’s standard that previously untreated CML patients (N = 120) have a median BCR-ABL:ABL ratio of 4.1325 from peripheral blood samples.
How is BCR-ABL calculated?
Which is the fusion protein encoded by BCR-ABL?
The fusion protein encoded by BCR-ABL varies in size, depending on the breakpoint in the BCR gene. Three breakpoint cluster regions have been characterized to date: major (M-bcr), minor (m-bcr) and micro (mu-bcr). The overwhelming majority of CML patients have a p210 BCR-ABL gene (M-bcr), whose mRNA transcripts have a b3a2 and/or a b2a2 junction.
Are there any rare cases of Bcr-Abl?
Rare cases of CML are due to a p190-type of BCR-ABL gene and, in these, the disease tends to have a prominent monocytic component, resembling CMML. CML resulting from a p230 BCR-ABL gene (mu-bcr breakpoint) is also rare, and has been associated with the CNL variant and/or with marked thrombocytosis.
Where can I find the BCR-ABL hybrid gene?
1 Department of Haematology, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom. The BCR-ABL hybrid gene, the main product of the t (9;22) (q34;q11) translocation, is found in the leukaemic clone of at least 95% of CML patients.
What are the breakpoint clusters for Bcr-Abl?
Three breakpoint cluster regions have been characterized to date: major (M-bcr), minor (m-bcr) and micro (mu-bcr). The overwhelming majority of CML patients have a p210 BCR-ABL gene (M-bcr), whose mRNA transcripts have a b3a2 and/or a b2a2 junction.
